Upper limits of intraocular pressure in glaucoma clinical trials

Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):84-5. doi: 10.1111/ceo.12357. Epub 2014 May 30.

Authors

David L DeMill¹, Barbara M Wirostko, Lindsay A Nelson, William C Stewart

Affiliation

¹ Department of Ophthalmology and Visual Science, University of Michigan, Ann Arbor, Michigan, USA.

PMID: 24801136
DOI: 10.1111/ceo.12357

No abstract available

Publication types

Letter
Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Antihypertensive Agents / therapeutic use
Circadian Rhythm
Glaucoma, Open-Angle / diagnosis*
Glaucoma, Open-Angle / drug therapy
Glaucoma, Open-Angle / physiopathology
Humans
Intraocular Pressure / physiology*
Ocular Hypertension / diagnosis*
Ocular Hypertension / drug therapy
Ocular Hypertension / physiopathology
Prostaglandins / therapeutic use
Randomized Controlled Trials as Topic
Time Factors
Tonometry, Ocular

Substances

Adrenergic beta-Antagonists
Antihypertensive Agents
Prostaglandins